CytoAgents, Inc’s Post

View organization page for CytoAgents, Inc, graphic

1,386 followers

CAR T-cell therapy is a revolutionary approach to treating certain types of cancer. And while this method has played a key role in boosting patient outcomes, there are significant risks involved. More than two-thirds of CAR T-cell therapy suffer from a dangerous side effect known as Cytokine Release Syndrome (CRS), which is an overreaction of the immune system. CytoAgents' mission is to develop an effective treatment for CRS, which will make CAR T-cell therapy safer for patients. Learn about our solution here: https://lnkd.in/eFasArrf #cytokinereleasesyndrome #crs #cytokines #cartcelltherapy Teresa Whalen, RPh

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics